Anemia of Chronic Kidney Disease: Which Therapeutics Are Available?

Authors

  • Sara Condeço Unidade de Saúde Familiar Novo Mirante. Agrupamento de Centros de Saúde de Loures-Odivelas. Lisboa.
  • Bernardo Marques da Silva Serviço de Nefrologia e Transplantação Renal. Centro Hospitalar Universitário Lisboa Norte. Lisboa. https://orcid.org/0000-0003-0665-4446

DOI:

https://doi.org/10.20344/amp.19381

Keywords:

Anemia/drug therapy, Renal Insufficiency, Chronic

Abstract

N/a.

Downloads

Download data is not yet available.

References

Farinha A, Robalo Nunes A, Mairos J, Fonseca C. Anemia da doença renal crónica: o estado da arte. Acta Med Port. 2022;35:758–64. DOI: https://doi.org/10.20344/amp.17284

European Medicines Agency. Roxadustat. 2022. [consultado 2022 nov 18]. Disponível em:https://www.ema.europa.eu/en/documents/product-information/evrenzo-epar-product-information_en.pdf.

Locatelli F, Minutolo R, de Nicola L, del Vecchio L. Evolving strategies in the treatment of anaemia in chronic kidney disease: the HIF-prolyl hydroxylase inhibitors. Drugs. 2022;82:1565–89. DOI: https://doi.org/10.1007/s40265-022-01783-3

McCallum W, Weiner DE. HIF-PHIs for anemia management in CKD. Clin J Am Soc Nephrol. 2022;17:1255–8. DOI: https://doi.org/10.2215/CJN.02440222

Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, et al. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) conference. Kidney Int. 2021;99:1280–95. DOI: https://doi.org/10.1016/j.kint.2021.03.020

Downloads

Published

2023-03-14

How to Cite

1.
Condeço S, Marques da Silva B. Anemia of Chronic Kidney Disease: Which Therapeutics Are Available?. Acta Med Port [Internet]. 2023 Mar. 14 [cited 2024 Nov. 22];36(4):299-. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/19381

Issue

Vol. 36 No. 4 (2023): April

Section

Letters to the Editor

License

Copyright (c) 2023 Acta Médica Portuguesa

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC